Methenamine hippurate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methenamine hippurate and what is the scope of patent protection?
Methenamine hippurate
is the generic ingredient in three branded drugs marketed by Ss Pharma, Aurobindo Pharma Ltd, Impax Labs Inc, Lyrus Life Sciences, Micro Labs, Novast Labs, and Alvogen, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are ten drug master file entries for methenamine hippurate. Eight suppliers are listed for this compound.
Summary for methenamine hippurate
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 7 |
NDAs: | 7 |
Drug Master File Entries: | 10 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 6 |
Patent Applications: | 3,250 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for methenamine hippurate |
What excipients (inactive ingredients) are in methenamine hippurate? | methenamine hippurate excipients list |
DailyMed Link: | methenamine hippurate at DailyMed |
Recent Clinical Trials for methenamine hippurate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Texas Southwestern Medical Center | Phase 4 |
Washington University School of Medicine | Phase 4 |
Medical Universtity of Lodz | Phase 4 |